Cargando…
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
Pancreatic cancer (PC) is one of the most lethal, chemoresistant malignancies and it is of paramount importance to find more effective therapeutic agents. Repurposing of non-anticancer drugs may expand the repertoire of effective molecules. Studies on repurposing of benzimidazole-based anthelmintics...
Autores principales: | Florio, Rosalba, Veschi, Serena, di Giacomo, Viviana, Pagotto, Sara, Carradori, Simone, Verginelli, Fabio, Cirilli, Roberto, Casulli, Adriano, Grassadonia, Antonino, Tinari, Nicola, Cataldi, Amelia, Amoroso, Rosa, Cama, Alessandro, De Lellis, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966614/ https://www.ncbi.nlm.nih.gov/pubmed/31861153 http://dx.doi.org/10.3390/cancers11122042 |
Ejemplares similares
-
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
por: Florio, Rosalba, et al.
Publicado: (2021) -
Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
por: De Lellis, Laura, et al.
Publicado: (2021) -
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective
por: Brocco, Davide, et al.
Publicado: (2020) -
Exosomes as Pleiotropic Players in Pancreatic Cancer
por: De Lellis, Laura, et al.
Publicado: (2021) -
Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning
por: Liang, Dong, et al.
Publicado: (2022)